Methylprednisolon Ace Pharmaceuticals (Methylprednisolone)

Methylprednisolone is a glucocorticoid used to treat a range of inflammatory and immune‑mediated diseases.

• Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility.
• Asthma: decreases airway inflammation, helping to control chronic symptoms.
• Severe allergic reactions: suppresses acute hypersensitivity responses.
• Dermatologic inflammatory conditions: alleviates skin redness, swelling and itching.
• Multiple sclerosis relapses: limits central nervous system inflammation during acute attacks.

• Methylprednisolone is a synthetic glucocorticoid that diffuses across cell membranes and binds intracellular glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus, where it interacts with glucocorticoid response elements, altering gene transcription. This up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, leading to reduced leukocyte migration, suppressed immune activation, and overall anti‑inflammatory and immunosuppressive effects.

Methylprednisolone may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects

• Increased appetite and weight gain.
• Insomnia or difficulty sleeping.
• Mood swings, irritability or euphoria.
• Elevated blood glucose levels.
• Gastrointestinal discomfort or dyspepsia.
• Fluid retention and mild edema.

Serious or Rare Side Effects

• Adrenal insufficiency on abrupt discontinuation.
• Severe infections due to immunosuppression.
• Osteoporosis and increased fracture risk.
• Cataracts or glaucoma.
• Psychosis or severe mood disorders.
• Anaphylactic or severe allergic reactions.

When prescribing methylprednisolone, clinicians should consider several safety measures.

• Assess infection risk: screen for active or latent infections before initiating therapy.
• Monitor blood glucose: patients with diabetes may require dose adjustments.
• Screen for osteoporosis: consider bone density testing for long‑term use.
• Use lowest effective dose: aim to minimize exposure while achieving therapeutic goals.
• Avoid abrupt discontinuation: taper gradually to prevent adrenal crisis.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methylprednisolone can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Systemic CYP3A4 inhibitors (e.g., ketoconazole): may increase corticosteroid exposure.
• Live vaccines: heightened risk of infection due to immunosuppression.
• Anticoagulants (e.g., warfarin): enhanced anticoagulant effect, increasing bleeding risk.
• NSAIDs: combined use raises the chance of gastrointestinal bleeding.
• Diabetes medications: may require dose reduction because of hyperglycaemic effect.

Moderate Interactions (Monitor Closely)

• Antihypertensives: corticosteroids can blunt blood‑pressure‑lowering effects.
• Non‑live vaccines: may reduce immunogenic response, monitor antibody titres.
• Moderate CYP3A4 substrates (e.g., certain antifungals): may modestly raise steroid levels.